Author Correction: Immunofluorescence can assess the efficacy of mTOR pathway therapeutic agent Everolimus in breast cancer models
Crossref DOI link: https://doi.org/10.1038/s41598-020-68553-7
Published Online: 2020-08-19
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kuo, Chun-Ting
Chen, Chen-Lin
Li, Chih-Chi
Huang, Guan-Syuan
Ma, Wei-Yuan
Hsu, Wei-Fan http://orcid.org/0000-0001-5722-6842
Lin, Ching-Hung
Lu, Yen-Shen
Wo, Andrew M.
Text and Data Mining valid from 2020-08-19
Version of Record valid from 2020-08-19
Article History
First Online: 19 August 2020